Senior woman losing parts of head feeling confused as symbol of decreased mind function.

Biomarker in the Eye Could Diagnose Neurodegeneration

Neurofilament light chain, a promising protein biomarker of neurodegeneration, has been identified in the cerebrospinal fluid and blood as a potential screening tool and prognostic indicator.

VA Extends Personalis Contract for Million Veterans Project with $31M Task Order

The new task order brings to about $175 million the cumulative value of task orders issued by the VA to Personalis, a Menlo Park, CA, company specializing in population sequencing and cancer genomics.
ersonal Genome Diagnostics (PGDx) said today that its 500+ gene pan-cancer tumor profiling tissue assay is being used by Merck & Co. in a Phase II clinical trial designed to assess patient response to a dual biomarker-directed precision oncology combination therapy in patients with previously untreated advanced non-small cell lung cancer (NSCLC).

Biocept’s NSCLC Liquid Biopsy Gains Coverage from Insurer Highmark

With its coverage determination, Highmark will reimburse testing with Biocept's assay in health insurances across the company’s market areas of Pennsylvania, Delaware, and West Virginia, where it serves 5.6 million members.

Small Sequencer Developer GenapSys Completes $90M Series C Financing

GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...

NIH Awards $129M in RADx Funding to Nine COVID-19 Test Developers

The latest funding brings to $378 million the total value of contracts awarded to 16 developers of advanced COVID-19 diagnostics through the Rapid Acceleration of Diagnostics (RADx) initiative.
Cloned Faces with digital background

Whole-Genome Sequencing Comes of Age in Clinical Care

In this Clinical OMICs KEYNOTE webinar, sponsored by Illumina, we are delighted to host two true pioneers of clinical genome sequencing, bioinformatician Dr. Liz Worthey and geneticist Dr. Howard Jacob, who will reflect on a decade of progress in clinical genome analysis and discuss the future challenges confronting the field.

Sherlock’s CRISPR-based SARS-CoV-2 Test Clears First Hurdle in Dartmouth-Hitchcock Pilot

Sherlock’s SARS-CoV-2 test kit has received Emergency use Authorization from the FDA and is designed for use in CLIA labs certified for performing high complexity tests.
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.

PGDx Applies CE Mark to Second Cancer Assay

Personal Genome Diagnostics (PGDx) said it has applied the CE mark to its PGDx elio tissue complete assay, a distinction the company said will enable...
Scroll Up